The Push–Pull of Industry in Interventional Cardiovascular Trials

Patrice Wendling

June 03, 2020

One in five trials (16.2%) were not prospectively registered before the start of enrollment, and at least one major discrepancy existed between the registered and published primary outcome in 38% of registered trials.

Click here to learn more about the article